Publications

• CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications. Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, Spector N, Molina-Kirsch HF, Warnke RA, Levy R, Natkunam Y. Am J Pathol. 2012; 181 (3): 795-803
• A multi-site study using high-resolution HLA genotyping by next generation sequencing. Holcomb CL, Höglund B, Anderson MW, Blake LA, Böhme I, Egholm M, Ferriola D, Gabriel C, Gelber SE, Goodridge D, Hawbecker S, Klein R, Ladner M, Lind C, Monos D, Pando MJ, Pröll J, Sayer DC, Schmitz-Agheguian G, Simen BB, Thiele B, Trachtenberg EA, Tyan DB, Wassmuth R, White S, Erlich HA. Tissue Antigens. 2011; 77 (3): 206-17
• C-C chemokine receptor 1 expression in human hematolymphoid neoplasia. Anderson MW, Zhao S, Ai WZ, Tibshirani R, Levy R, Lossos IS, Natkunam Y. Am J Clin Pathol. 2010; 133 (3): 473-83
• Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. Metcalf RA, Zhao S, Anderson MW, Lu ZS, Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunam Y. Mod Pathol. 2010; 23 (3): 420-33
• HLA-DM mediates epitope selection by a "compare-exchange" mechanism when a potential peptide pool is available. Ferrante A, Anderson MW, Klug CS, Gorski J. PLoS One. 2008; 3 (11): e3722